Interim Design Modifications in Time-to-Event Studies

被引:20
作者
Irle, Sebastian [1 ]
Schaefer, Helmut [1 ]
机构
[1] Univ Marburg, Inst Med Biometry & Epidemiol, D-35037 Marburg, Germany
关键词
Adaptive design; Clinical trial; Conditional distribution; Conditional rejection probability; CRP principle; Logrank statistic; SEQUENTIAL-ANALYSIS; SAMPLE-SIZE; TESTS;
D O I
10.1080/01621459.2011.644141
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
We propose a flexible method for interim design modifications in time-to-event studies. With this method, it is possible to inspect the data at any time during the course of the study, without the need for prespecification of a learning phase, and to make certain types of design modifications depending on the interim data without compromising the Type I error risk. The method can be applied to studies designed with a conventional statistical test, fixed sample, or group sequential, even when no adaptive interim analysis and no specific method for design adaptations (such as combination tests) had been foreseen in the protocol. Currently, the method supports design changes such as an extension of the recruitment or follow-up period, as well as certain modifications of the number and the schedule of interim analyses as well as changes of inclusion criteria. In contrast to existing methods offering the same flexibility, our approach allows us to make use of the full interim information collected until the time of the adaptive data inspection. This includes time-to-event data from patients who have already experienced an event at the time of the data inspection, and preliminary information from patients still alive, even if this information is predictive for survival, such as early treatment response in a cancer clinical trial. Our method is an extension of the so-called conditional rejection probability (CRP) principle. It is based on the conditional distribution of the test statistic given the final value of the same test statistic from a subsample, namely the learning sample. It is developed in detail for the example of the logrank statistic, for which we derive this conditional distribution using martingale techniques.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 22 条
[1]  
ANDERSEN P. K., 1995, SPRINGER SERIES STAT
[2]  
[Anonymous], 1991, Counting Processes and Survival Analysis
[3]  
Bauer P, 2004, Stat Med, V23, P1333, DOI 10.1002/sim.1759
[4]   EVALUATION OF EXPERIMENTS WITH ADAPTIVE INTERIM ANALYSES [J].
BAUER, P ;
KOHNE, K .
BIOMETRICS, 1994, 50 (04) :1029-1041
[5]   Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology [J].
Brannath, Werner ;
Zuber, Emmanuel ;
Branson, Michael ;
Bretz, Frank ;
Gallo, Paul ;
Posch, Martin ;
Racine-Poon, Amy .
STATISTICS IN MEDICINE, 2009, 28 (10) :1445-1463
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   Adaptive trial design: A general methodology for censored time to event data [J].
Jahn-Eimermacher, Antje ;
Ingel, Katharina .
CONTEMPORARY CLINICAL TRIALS, 2009, 30 (02) :171-177
[8]   An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints [J].
Jenkins, Martin ;
Stone, Andrew ;
Jennison, Christopher .
PHARMACEUTICAL STATISTICS, 2011, 10 (04) :347-356
[9]   Adaptive sample size calculations in group sequential trials [J].
Lehmacher, W ;
Wassmer, G .
BIOMETRICS, 1999, 55 (04) :1286-1290
[10]   Phase 2 and 3 combination designs to accelerate drug development [J].
Liu, Q ;
Pledger, GW .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2005, 100 (470) :493-502